FI874596A0 - Peptidpreparat. - Google Patents
Peptidpreparat.Info
- Publication number
- FI874596A0 FI874596A0 FI874596A FI874596A FI874596A0 FI 874596 A0 FI874596 A0 FI 874596A0 FI 874596 A FI874596 A FI 874596A FI 874596 A FI874596 A FI 874596A FI 874596 A0 FI874596 A0 FI 874596A0
- Authority
- FI
- Finland
- Prior art keywords
- peptidpreparat
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK503386 | 1986-10-20 | ||
DK503386A DK503386D0 (da) | 1986-10-20 | 1986-10-20 | Peptidpraeparater |
DK356987A DK356987D0 (fi) | 1987-07-10 | 1987-07-10 | |
DK356987 | 1987-07-10 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI874596A0 true FI874596A0 (fi) | 1987-10-19 |
FI874596A FI874596A (fi) | 1988-04-21 |
FI86254B FI86254B (fi) | 1992-04-30 |
FI86254C FI86254C (fi) | 1992-08-10 |
Family
ID=26067111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI874596A FI86254C (fi) | 1986-10-20 | 1987-10-19 | Foerfarande foer framstaellning av insulinpreparat. |
Country Status (18)
Country | Link |
---|---|
US (1) | US5070186A (fi) |
EP (1) | EP0265213B1 (fi) |
KR (1) | KR880004819A (fi) |
CN (1) | CN87107049A (fi) |
AU (1) | AU616381B2 (fi) |
CA (1) | CA1316819C (fi) |
DE (1) | DE3778287D1 (fi) |
ES (1) | ES2033871T3 (fi) |
FI (1) | FI86254C (fi) |
GR (1) | GR3004912T3 (fi) |
HU (1) | HU201475B (fi) |
IE (1) | IE60264B1 (fi) |
IL (1) | IL84203A (fi) |
NO (1) | NO170754C (fi) |
NZ (1) | NZ222214A (fi) |
PH (1) | PH23446A (fi) |
PT (1) | PT85949B (fi) |
YU (1) | YU46665B (fi) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5534488A (en) * | 1993-08-13 | 1996-07-09 | Eli Lilly And Company | Insulin formulation |
YU18596A (sh) * | 1995-03-31 | 1998-07-10 | Eli Lilly And Company | Analogne formulacije monomernog insulina |
ATE290877T1 (de) * | 1998-01-09 | 2005-04-15 | Novo Nordisk As | Stabilisierte insulin-zubereitungen |
US7678364B2 (en) | 1999-08-25 | 2010-03-16 | Alkermes, Inc. | Particles for inhalation having sustained release properties |
DE10114178A1 (de) * | 2001-03-23 | 2002-10-10 | Aventis Pharma Gmbh | Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität |
WO2003017915A1 (en) * | 2001-08-27 | 2003-03-06 | Novo Nordisk A/S | A cartridge and a medical delivery system accommodating such a cartridge |
US9376479B2 (en) * | 2002-12-31 | 2016-06-28 | Anjinomoto Althea, Inc. | Human growth hormone crystals and methods for preparing them |
BR0317896A (pt) * | 2002-12-31 | 2005-12-06 | Altus Pharmaceuticals Inc | Complexos de cristais de proteìna e polìmeros iÈnicos |
US20090023629A1 (en) * | 2005-12-23 | 2009-01-22 | Altus Pharmaceuticals Inc. | Compositions comprising polycation-complexed protein crystals and methods of treatment using them |
ES2542146T3 (es) | 2006-07-31 | 2015-07-31 | Novo Nordisk A/S | Insulinas extendidas PEGiladas. |
WO2008034881A1 (en) | 2006-09-22 | 2008-03-27 | Novo Nordisk A/S | Protease resistant insulin analogues |
US9387176B2 (en) | 2007-04-30 | 2016-07-12 | Novo Nordisk A/S | Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein |
EP2152243A2 (en) * | 2007-04-30 | 2010-02-17 | Novo Nordisk A/S | Highly concentrated insulin solutions and compositions |
ES2618073T3 (es) | 2008-03-14 | 2017-06-20 | Novo Nordisk A/S | Análogos de insulina estabilizados frente a proteasas |
WO2009115469A1 (en) | 2008-03-18 | 2009-09-24 | Novo Nordisk A/S | Protease stabilized, acylated insulin analogues |
WO2010043566A2 (de) | 2008-10-17 | 2010-04-22 | Sanofi-Aventis Deutschland Gmbh | Kombination von einem insulin und einem glp-1-agonisten |
PT2554183T (pt) | 2009-11-13 | 2018-07-09 | Sanofi Aventis Deutschland | Composição farmacêutica que compreende um agonista de glp-1, uma insulina e metionina |
PL3345593T3 (pl) | 2009-11-13 | 2024-04-08 | Sanofi-Aventis Deutschland Gmbh | Kompozycja farmaceutyczna zawierająca desPro36-eksendynę-4(1-39)-Lys6-NH2 i metioninę |
CN101912600B (zh) * | 2010-01-11 | 2014-01-29 | 杨国汉 | 改善胰岛素在溶液中稳定性的方法 |
US8637458B2 (en) * | 2010-05-12 | 2014-01-28 | Biodel Inc. | Insulin with a stable basal release profile |
AU2011202239C1 (en) | 2010-05-19 | 2017-03-16 | Sanofi | Long-acting formulations of insulins |
SI2611458T1 (sl) | 2010-08-30 | 2017-01-31 | Sanofi-Aventis Deutschland Gmbh | Uporaba AVE0010 za izdelavo zdravila za zdravljenje sladkorne bolezni tipa 2 |
US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
CA2846413C (en) | 2011-08-29 | 2021-11-02 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for use in glycemic control in diabetes type 2 patients |
AR087744A1 (es) | 2011-09-01 | 2014-04-16 | Sanofi Aventis Deutschland | Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa |
CN104364260B (zh) | 2012-04-11 | 2017-02-22 | 诺和诺德股份有限公司 | 胰岛素制剂 |
US9399065B2 (en) | 2012-04-16 | 2016-07-26 | Biodel Inc. | Magnesium compositions for modulating the pharmacokinetics and injection site pain of insulin |
US9381247B2 (en) * | 2012-04-16 | 2016-07-05 | Biodel Inc. | Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain |
WO2014161837A1 (en) | 2013-04-03 | 2014-10-09 | Sanofi | Treatment of diabetes mellitus by long–acting formulations of insulins |
US9896496B2 (en) | 2013-10-07 | 2018-02-20 | Novo Nordisk A/S | Derivative of an insulin analogue |
JP6970615B2 (ja) | 2014-12-12 | 2021-11-24 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | インスリングラルギン/リキシセナチド固定比処方 |
TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患治療 |
TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患之治療 |
RS62295B1 (sr) | 2016-12-16 | 2021-09-30 | Novo Nordisk As | Farmaceutskе kompozicijе kojе sadržе insulin |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2076082A (en) * | 1935-04-08 | 1937-04-06 | Nordisk Insulinlab | Therapeutic product and process |
US2179384A (en) * | 1937-04-05 | 1939-11-07 | Univ Alberta | Therapeutic composition and process of making it |
US2190134A (en) * | 1939-06-09 | 1940-02-13 | Norton Co | Grinding machine |
US2538018A (en) * | 1944-04-04 | 1951-01-16 | Nordisk Insulinlab | Crystalline product of insulin and alkaline protein and process of making it |
US2474729A (en) * | 1945-01-03 | 1949-06-28 | Rhone Poulenc Sa | Insulin preparations |
US2801953A (en) * | 1952-02-28 | 1957-08-06 | Hoechst Ag | Process of preparing crystallized insulin preparations |
US3102077A (en) * | 1953-08-19 | 1963-08-27 | Christensen Henry Marinus | Preparation of insulin containing 2.75 to 8 percent zinc content |
DK98342C (da) * | 1959-06-16 | 1964-03-31 | Henry Marinus Dr Christensen | Fremgangsmåde til fremstilling af et insulinpræparat til peroral applikation. |
US3868358A (en) * | 1971-04-30 | 1975-02-25 | Lilly Co Eli | Protamine-insulin product |
GB1426061A (en) * | 1972-12-28 | 1976-02-25 | Ici Ltd | Polypeptides |
US3856771A (en) * | 1973-07-16 | 1974-12-24 | Lilly Co Eli | Process for manufacturing alkali metal or ammonium insulin |
US4196196A (en) * | 1978-06-19 | 1980-04-01 | Tiholiz Ivan C | Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states |
AU550068B2 (en) * | 1981-03-10 | 1986-02-27 | Novo Nordisk A/S | Zinc insulin stabilized with calcium or magnesium salts |
US4839341A (en) * | 1984-05-29 | 1989-06-13 | Eli Lilly And Company | Stabilized insulin formulations |
US4764592A (en) * | 1987-04-23 | 1988-08-16 | Eli Lilly And Company | Crystalline human proinsulin and process for its production |
-
1987
- 1987-10-14 PH PH35937A patent/PH23446A/en unknown
- 1987-10-19 NO NO874347A patent/NO170754C/no unknown
- 1987-10-19 DE DE8787309229T patent/DE3778287D1/de not_active Expired - Fee Related
- 1987-10-19 YU YU191887A patent/YU46665B/sh unknown
- 1987-10-19 ES ES198787309229T patent/ES2033871T3/es not_active Expired - Lifetime
- 1987-10-19 IL IL84203A patent/IL84203A/xx not_active IP Right Cessation
- 1987-10-19 PT PT85949A patent/PT85949B/pt unknown
- 1987-10-19 HU HU874683A patent/HU201475B/hu not_active IP Right Cessation
- 1987-10-19 EP EP87309229A patent/EP0265213B1/en not_active Expired - Lifetime
- 1987-10-19 AU AU79907/87A patent/AU616381B2/en not_active Ceased
- 1987-10-19 IE IE279987A patent/IE60264B1/en not_active IP Right Cessation
- 1987-10-19 FI FI874596A patent/FI86254C/fi not_active IP Right Cessation
- 1987-10-19 NZ NZ222214A patent/NZ222214A/xx unknown
- 1987-10-20 CN CN198787107049A patent/CN87107049A/zh not_active Withdrawn
- 1987-10-20 KR KR870011644A patent/KR880004819A/ko not_active Application Discontinuation
- 1987-10-20 CA CA000549713A patent/CA1316819C/en not_active Expired - Fee Related
-
1989
- 1989-04-19 US US07/340,331 patent/US5070186A/en not_active Expired - Fee Related
-
1992
- 1992-06-11 GR GR920401262T patent/GR3004912T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR3004912T3 (fi) | 1993-04-28 |
NO170754B (no) | 1992-08-24 |
IE60264B1 (en) | 1994-06-29 |
ES2033871T3 (es) | 1993-04-01 |
FI86254B (fi) | 1992-04-30 |
NO874347D0 (no) | 1987-10-19 |
HUT46232A (en) | 1988-10-28 |
PH23446A (en) | 1989-08-07 |
PT85949A (en) | 1987-11-01 |
AU616381B2 (en) | 1991-10-31 |
EP0265213A2 (en) | 1988-04-27 |
YU46665B (sh) | 1994-01-20 |
AU7990787A (en) | 1988-04-21 |
US5070186A (en) | 1991-12-03 |
FI86254C (fi) | 1992-08-10 |
NO874347L (no) | 1988-04-21 |
CA1316819C (en) | 1993-04-27 |
CN87107049A (zh) | 1988-07-06 |
IE872799L (en) | 1988-04-20 |
KR880004819A (ko) | 1988-06-27 |
DE3778287D1 (de) | 1992-05-21 |
EP0265213A3 (en) | 1988-11-09 |
HU201475B (en) | 1990-11-28 |
EP0265213B1 (en) | 1992-04-15 |
YU191887A (en) | 1989-04-30 |
NO170754C (no) | 1992-12-02 |
NZ222214A (en) | 1989-11-28 |
IL84203A (en) | 1993-04-04 |
PT85949B (pt) | 1990-07-31 |
FI874596A (fi) | 1988-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE70057T1 (de) | Antitumormittel. | |
DE3775679D1 (de) | Vernebler. | |
DE3767169D1 (de) | Sportschuh. | |
ATE57924T1 (de) | 3-aryloxy-3-substituierte-propanamine. | |
DE3764043D1 (de) | Alkylendiamine. | |
ATE63533T1 (de) | Xylolisomerisierung. | |
DE3779761D1 (de) | Abseilgeraet. | |
DE3771918D1 (de) | Chinolinamide. | |
DE3785294D1 (de) | Neigungsmesser. | |
DE3786679D1 (de) | Schmitt-triggerschaltung. | |
DE3773636D1 (de) | Saeurebeschleunigte hydrocarboxilierung. | |
DE3771271D1 (de) | Fluorphthalimide. | |
FI860054A0 (fi) | Motionsanordning. | |
DE3779382D1 (de) | 3-6-diphenylpyridazine. | |
DE3763648D1 (de) | Rollski. | |
FI860046A0 (fi) | Foerlaengningsanordning foer traefaner. | |
DE3766410D1 (de) | Methylalkylcyclosiloxane. | |
DE3669032D1 (de) | Okulopressionsgeraet. | |
DE3770459D1 (de) | 3-halogensuccinimide. | |
DE3764485D1 (de) | Polyglycidylamine. | |
FI860072A0 (fi) | Mataranordning foer en spannmaolstork. | |
FI851776L (fi) | Elkandelaber. | |
FI73944B (fi) | Rullningsanordning foer pappersbana. | |
FI77950B (fi) | Foergreningsklaemma foer en sektorformig kapad huvudledning. | |
FI77957B (fi) | Taendnings- och matarkoppling foer lyslampor. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed | ||
MM | Patent lapsed |
Owner name: NOVO NORDISK A/S |